Press releases

BioArctic strengthens its blood-brain barrier technology platform with world leading scientist recruitment

May 23, 2019 - Other press release

Stockholm, Sweden, May 23, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has recruited the internationally renowned scientist Dr. ...

BioArctic: Alzheimer’s Clinical Trials Consortium and Eisai announce BAN2401 to be evaluated in clinical study for prevention of Alzheimer’s disease

May 10, 2019 - Other press release

Stockholm, Sweden, May 10, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) informed today that the Alzheimer’s Clinical Trials Consortium (ACTC) and BioArctic’s partner ...

BioArctic’s Board of Directors and management increase their shareholdings

May 9, 2019 - Other press release

Stockholm, Sweden, May 9, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that nine members of the company's Board and management today have called ...

Invitation to presentation of BioArctic’s Interim Report for the first quarter of 2019 on May 9, at 9.30 a.m. CET

April 29, 2019 - Other press release

Stockholm, Sweden, April 29, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Interim Report for the period January – March 2019 ...

BioArctic receives grant from Vinnova for a collaborative research project to increase brain uptake of antibodies

April 3, 2019 - Other press release

Stockholm, Sweden, April 3, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that the company has received a non-diluting grant of MSEK 5 ...

BioArctic’s partner Eisai to give poster presentations on BAN2401 in early Alzheimer’s disease at the AD/PD conference in Lisbon

March 25, 2019 - Other press release

Stockholm, Sweden, March 25, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announces that its partner Eisai will give poster presentations related to BAN2401 in ...

Invitation to presentation of BioArctic’s Full Year Report 2018 on February 14, 2019

February 7, 2019 - Other press release

Stockholm, Sweden, February 7, 2019 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Full Year Report for the period January – December ...

BioArctic employs Gunilla Andersson as Senior Director HR

December 19, 2018 - Other press release

Stockholm, Sweden, December 19, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that Gunilla Andersson assumes the new position as Senior Director HR ...

BioArctic to present at Jefferies 2018 London Healthcare Conference on November 15

November 13, 2018 - Other press release

Stockholm, Sweden, November 13, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) will present at Jefferies 2018 London Healthcare Conference on November 15, at 4.40 ...

Invitation to presentation of BioArctic’s Interim Report for the period January – September 2018 on November 8, 2018

October 30, 2018 - Other press release

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Interim Report for the period January – September 2018 on Thursday, November 8, 2018 at ...

BioArctic: Eisai to present additional data from BAN2401 Phase 2b study in early Alzheimer’s disease and the presentation will be webcast live from CTAD

October 18, 2018 - Other press release

Stockholm, Sweden, October 18, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) announced today that Eisai will present additional data on the anti-amyloid (Aβ) ...

Invitation to presentation of BioArctic’s Interim Report for the period January – June 2018 on August 23, 2018

August 14, 2018 - Other press release

Stockholm, Sweden, August 14, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Interim Report for the period January – June 2018 ...

BioArctic receives this year’s SwedenBIO Award

May 16, 2018 - Other press release

Stockholm, Sweden, May 16, 2018 – BioArctic AB today received the SwedenBIO Award 2018. The prize is awarded to a company that has distinguished itself by ...

Invitation to presentation of BioArctic’s Interim Report January – March 2018 on April 26, 2018

April 12, 2018 - Other press release

Stockholm, Sweden, April 12, 2018 – BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) to publish the company’s Interim Report for the period January – March 2018 ...

EXERCISE OF OVER-ALLOTMENT OPTION AND END OF THE STABILIZATION PERIOD

November 6, 2017 - Other press release

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH ...

Invitation to presentation of BioArctic’s Interim Report January – September 2017 on November 8

November 3, 2017 - Other press release

BioArctic AB (publ) (Nasdaq Stockholm: BIOA B) publishes the company’s Interim Report for the period January – September 2017 on November 8, 2017 at 08:00 a.m. ...

Stabilization notice

October 20, 2017 - Other press release

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH ...

Trading in BioArctic’s B-shares commences today on Nasdaq Stockholm

October 12, 2017 - Other press release

THIS ANNOUNCEMENT AND THE INFORMATION CONTAINED HEREIN IS NOT FOR DISTRIBUTION IN OR INTO THE UNITED STATES, AUSTRALIA, CANADA, JAPAN OR ANY OTHER JURISDICTION IN WHICH ...